MetaADEDB 2.0 @ LMMD
Sodium Oxybate
(XYGBKMMCQDZQOZ-UHFFFAOYSA-M)
Structure
SMILES
OCCCC(=O)[O-].[Na+]
Type(s)
Approved
ATC code(s)
N01AX11; N07XX04
Molecular Formula:
C4H7NaO3
Molecular Weight:
126.086
Log P:
-1.4912
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
60.36
CAS Number(s):
502-85-2
Synonym(s)
1.
Sodium Oxybate
2.
4-Hydroxybutyrate Sodium
3.
Oxybate Sodium
4.
Sodium Oxybutyrate
5.
Sodium gamma-Hydroxybutyrate
6.
gamma-Hydroxybutyrate
7.
Somsanit
8.
Xyrem
9.
4 Hydroxybutyrate Sodium
10.
Oxybate, Sodium
11.
Oxybutyrate, Sodium
12.
Sodium gamma Hydroxybutyrate
13.
gamma Hydroxybutyrate
External Link(s)
MeSHD012978
PubChem Compound23663870
CHEMBLCHEMBL1200682
DrugBankDB09072
KEGGdr:D05866
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AgitationFAERS: 3US FAERS
2HeadacheFAERS: 3US FAERS
3SomnolenceFAERS: 3US FAERS
4AmnesiaFAERS: 2US FAERS
5AnxietyFAERS: 2US FAERS
6CyanosisFAERS: 2US FAERS
7DizzinessFAERS: 2US FAERS
8Drug DependenceFAERS: 2US FAERS
9Drug withdrawal syndromeFAERS: 2US FAERS
10HyperventilationFAERS: 2US FAERS
11Respiratory arrestFAERS: 2US FAERS
12Sinus TachycardiaFAERS: 2US FAERS
13VomitingFAERS: 2US FAERS
14Blood creatine phosphokinase increasedFAERS: 1US FAERS
15Cheyne-Stokes RespirationFAERS: 1US FAERS
16ChillsFAERS: 1US FAERS
17DeliriumFAERS: 1US FAERS
18KetosisFAERS: 1US FAERS
19LethargyFAERS: 1US FAERS
20Myasthenia GravisFAERS: 1US FAERS
21Oropharyngeal painFAERS: 1US FAERS
22PalpitationsFAERS: 1US FAERS
23Product taste abnormalFAERS: 1US FAERS
24Product use issueFAERS: 1US FAERS
25RhinitisFAERS: 1US FAERS
26Sleep TalkingFAERS: 1US FAERS
27Sleep-related eating disorderFAERS: 1US FAERS
28SomnambulismFAERS: 1US FAERS
29Suicide attemptFAERS: 1US FAERS
30Toxicity to various agentsFAERS: 1US FAERS
31Unresponsive to stimuliFAERS: 1US FAERS
32Urinary tract infectionFAERS: 1US FAERS
33Victim of chemical submissionFAERS: 1US FAERS
34Cardiomyopathy, Dilated15899737CTD
35Catalepsy14729119
18446324		CTD
36Chemical and Drug Induced Liver Injury15899737CTD
37Essential Tremor19497322CTD
38Hypokinesia16990508CTD
39Liver Failure, Acute15899737CTD
40Narcolepsy18446324CTD
41Seizures1718012CTD
42Substance Withdrawal Syndrome15715821CTD
43Substance-Related Disorders15715821CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.